Legal status · Australia
Is FOXO4-DRI legal in Australia?
No. FOXO4-DRI is not an approved medicine in Australia; its classification is "Not approved; prohibited in sport (WADA)". Nothing containing it is authorized for any use in people. Vials labeled "for research use only" are not exempt: that label does not make human use lawful. Human evidence: Preliminary.
FOXO4-DRI in Australia at a glance
| Classification | Not approved; prohibited in sport (WADA) |
|---|---|
| TGA approval status | Not approved by TGA |
| Evidence level | Preliminary (research strength: Preliminary) |
| Reviewed | Sep 2026 |
Classification and note come from the FOXO4-DRI profile, checked against Therapeutic Goods Administration (TGA) listings at the reviewed date.
What this means
- 01
No product containing FOXO4-DRI is approved by TGA for any use in Australia, so nothing on the market is authorized for people.
- 02
"Research use only" is a vendor label, not a legal category that permits human use. It does not exempt a product from medicines law.
- 03
Importing, supplying or promoting it for human use can fall under medicines legislation in Australia. This page is general information, not legal advice.
What FOXO4-DRI is
An experimental senolytic peptide that selectively triggers death of senescent cells in animal studies.
FOXO4-DRI is a designed peptide that disrupts the interaction between FOXO4 and p53 inside senescent cells, releasing p53 to trigger their apoptosis. In progeroid and aged mice it reversed markers of frailty and improved organ function.
Mechanism: Disrupts the FOXO4-p53 interaction selectively in senescent cells, allowing p53 to initiate targeted apoptosis of those cells.
Regulatory history: Not FDA-approved; experimental
How TGA treats this kind of product
Registers or lists therapeutic goods on the ARTG and schedules substances in the Poisons Standard. Many peptides are Schedule 4 (prescription only), so possession without a prescription and personal importation are restricted even when no product is registered.
The classification above is the The Longevity Archive reading of Therapeutic Goods Administration listings for FOXO4-DRI at the reviewed date, not a legal opinion. Rules change, and importing, prescribing and possessing a compound can each be treated differently. Check the regulator directly before acting on anything here.
FOXO4-DRI in other countries
Frequently asked questions
Is FOXO4-DRI legal in Australia?
No. FOXO4-DRI is not an approved medicine in Australia; its classification is "Not approved; prohibited in sport (WADA)". Nothing containing it is authorized for any use in people. Vials labeled "for research use only" are not exempt: that label does not make human use lawful. Human evidence: Preliminary.
Can I buy FOXO4-DRI in Australia?
No approved product exists to buy. In Australia FOXO4-DRI is classified as "Not approved; prohibited in sport (WADA)", so there is no licensed pharmacy product. Vendors selling it "for research use only" are not selling it for human use, and that label does not change its legal status. This site does not list or recommend vendors.
Is FOXO4-DRI TGA approved?
No. In Australia FOXO4-DRI is classified as "Not approved; prohibited in sport (WADA)", which is not a TGA marketing approval. For comparison, the US FDA status is: Not FDA-approved; experimental. Evidence level: Preliminary.
Related compounds in Australia
Full research profile
Mechanism, cited studies, FDA status and the full legal summary for FOXO4-DRI live on its compound profile.
FOXO4-DRI profileThis page is general information about the regulatory status of FOXO4-DRI in Australia, current as of Sep 2026. It is not legal advice, and classifications change; check Therapeutic Goods Administration directly or consult a lawyer for a specific situation. Educational use only. This database summarizes published research. It is not medical advice and contains no dosing protocols or recommendations for personal use. The Longevity Archive has no vendor relationships and does not recommend where to buy anything.